Veri-T: A Phase 1, Randomized, Double-Blind, Placebo- Controlled, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of Oral Verdiperstat (BHV-3241) in Patients With Semantic Variant Primary Progressive Aphasia (svPPA

Project: Non Profit

Project Details

StatusActive
Effective start/end date6/15/239/30/24